NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Claxton L, Simmonds M, Beresford L, et al. Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation. Southampton (UK): NIHR Journals Library; 2022 Jan. (Health Technology Assessment, No. 26.4.)
Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation.
Show details- 6MWT
6-minute walk test
- ACE
angiotensin-converting enzyme
- ACM
all-cause mortality
- BNF
British National Formulary
- BNP
B-type natriuretic peptide
- CEAC
cost-effectiveness acceptability curve
- CENTRAL
Cochrane Central Register of Controlled Trials
- CHF
chronic heart failure
- CI
confidence interval
- co-Q10
coenzyme Q10
- CPRD
Clinical Practice Research Datalink
- ECHOES
EchoCardiographic Heart Of England Screening
- EPHESUS
Eplerenone Post-AMI Heart Failure Efficacy and Survival Study
- EQ-5D
EuroQol-5 Dimensions
- EVPI
expected value of perfect information
- FAS
full analysis set
- GLMM
generalised linear mixed model
- GP
general practitioner
- HES
Hospital Episode Statistics
- HFpEF
heart failure with a preserved ejection fraction
- HFrEF
heart failure with a reduced ejection fraction
- HR
hazard ratio
- HRG
Healthcare Resource Group
- HRQoL
health-related quality of life
- ICER
incremental cost-effectiveness ratio
- IPD
individual participant data
- IQR
interquartile range
- LVEF
left ventricular ejection fraction
- LVSD
left ventricular systolic dysfunction
- MD
mean difference
- MI
myocardial infarction
- MLWHFQ
Minnesota Living with Heart Failure Questionnaire
- NICE
National Institute for Health and Care Excellence
- NMA
network meta-analysis
- NT-pro-BNP
N-terminal pro-B-type natriuretic peptide
- NYHA
New York Heart Association
- ONS
Office for National Statistics
- OR
odds ratio
- PRISMA
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
- QALY
quality-adjusted life-year
- QoL
quality of life
- RCT
randomised controlled trial
- RR
relative risk
- SHIFT
Systolic Heart failure treatment with the IF inhibitor ivabradine Trial
- SHOCS
Scale for Heart failure to Optimise Clinical Status
- SMD
standardised mean difference
- THIN
The Health Improvement Network
- VOI
value of information
- List of abbreviations - Coenzyme Q10 to manage chronic heart failure with a redu...List of abbreviations - Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation
- Independent economic assessment - Enzyme-linked immunosorbent assays for monitor...Independent economic assessment - Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation
- Discussion - Sixteen-week versus standard eight-week prednisolone therapy for ch...Discussion - Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT
- Background - Antidepressants for pain management in adults with chronic pain: a ...Background - Antidepressants for pain management in adults with chronic pain: a network meta-analysis
- Conclusions - Different strategies for pharmacological thromboprophylaxis for lo...Conclusions - Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation
Your browsing activity is empty.
Activity recording is turned off.
See more...